$FGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIBROGEN INC. Get notifications about new insider transactions in FIBROGEN INC for free.
Page: < prev 1 ... 10 11 12 13 14
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 22.08 | 13,500 | 298,080 | 3,883,781 | 3.9 M to 3.9 M (-0.35 %) |
| Jul 07 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Sell | S | 22.83 | 2,600 | 59,358 | 204,654 | 207.3 K to 204.7 K (-1.25 %) |
| Jul 07 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Sell | S | 22.56 | 2,781 | 62,739 | 207,254 | 210 K to 207.3 K (-1.32 %) |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 9,469 | 22,252 | 381,062 | |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 9,469 | 22,252 | 390,531 | |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 9,469 | 22,252 | 3,897,281 | 3.9 M to 3.9 M (+0.24 %) |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 23.52 | 13,500 | 317,520 | 3,887,812 | 3.9 M to 3.9 M (-0.35 %) |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 9,469 | 22,252 | 3,901,312 | 3.9 M to 3.9 M (+0.24 %) |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 23.93 | 500 | 11,965 | 3,891,843 | 3.9 M to 3.9 M (-0.01 %) |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 23.60 | 11,031 | 260,332 | 3,892,343 | 3.9 M to 3.9 M (-0.28 %) |
| Jun 26 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 23.62 | 1,969 | 46,508 | 3,903,374 | 3.9 M to 3.9 M (-0.05 %) |
| Jun 16 2015 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 6,400 | 18,560 | 350 | |
| Jun 16 2015 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 2.90 | 5,600 | 16,240 | 0 | |
| Jun 16 2015 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 2.90 | 12,000 | 34,800 | 111,199 | 99.2 K to 111.2 K (+12.10 %) |
| Jun 16 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | C | 0.00 | 60,000 | 0 | 0 | |
| Jun 16 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | C | 0.00 | 39,840 | 0 | 107,840 | 68 K to 107.8 K (+58.59 %) |
| Jun 05 2015 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 05 2015 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 18.34 | 12,000 | 220,080 | 12,000 | |
| Jun 02 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 17.50 | 2,282 | 39,935 | 3,905,343 | 3.9 M to 3.9 M (-0.06 %) |
| Jun 02 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Payment of Exercise | F | 17.50 | 657 | 11,498 | 210,035 | 210.7 K to 210 K (-0.31 %) |
| Jun 02 2015 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Payment of Exercise | F | 17.50 | 704 | 12,320 | 84,748 | 85.5 K to 84.7 K (-0.82 %) |
| Jun 02 2015 | FGEN | FIBROGEN INC | Controneo Pat | VP, Finance and CFO | Payment of Exercise | F | 17.50 | 657 | 11,498 | 99,199 | 99.9 K to 99.2 K (-0.66 %) |
| May 22 2015 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | M | 18.00 | 12,000 | 216,000 | 0 | |
| May 22 2015 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | M | 18.00 | 6,000 | 108,000 | 0 | |
| May 22 2015 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Buy | M | 18.00 | 18,000 | 324,000 | 161,068 | 143.1 K to 161.1 K (+12.58 %) |
| May 18 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 21.39 | 9,337 | 199,718 | 3,907,625 | 3.9 M to 3.9 M (-0.24 %) |
| May 18 2015 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Payment of Exercise | F | 21.39 | 2,906 | 62,159 | 85,452 | 88.4 K to 85.5 K (-3.29 %) |
| May 18 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | M | 3.50 | 4,000 | 14,000 | 8,000 | |
| May 18 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | M | 2.90 | 4,000 | 11,600 | 0 | |
| May 18 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Buy | M | 3.50 | 4,000 | 14,000 | 210,692 | 206.7 K to 210.7 K (+1.94 %) |
| May 18 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Buy | M | 2.90 | 4,000 | 11,600 | 206,692 | 202.7 K to 206.7 K (+1.97 %) |
| May 18 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Payment of Exercise | F | 21.39 | 2,712 | 58,010 | 202,692 | 205.4 K to 202.7 K (-1.32 %) |
| May 18 2015 | FGEN | FIBROGEN INC | Controneo Pat | VP, Finance and CFO | Payment of Exercise | F | 21.39 | 2,712 | 58,010 | 99,856 | 102.6 K to 99.9 K (-2.64 %) |
| Mar 17 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | A | 29.66 | 64,136 | 1,902,274 | 64,136 | |
| Mar 17 2015 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Grant | A | 0.00 | 32,068 | 0 | 203,068 | 171 K to 203.1 K (+18.75 %) |
| Mar 17 2015 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | A | 29.66 | 68,717 | 2,038,146 | 68,717 | |
| Mar 17 2015 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Grant | A | 0.00 | 34,358 | 0 | 88,358 | 54 K to 88.4 K (+63.63 %) |
| Mar 17 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | A | 29.66 | 147,600 | 4,377,816 | 147,600 | |
| Mar 17 2015 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Grant | A | 0.00 | 73,800 | 0 | 3,916,962 | 3.8 M to 3.9 M (+1.92 %) |
| Mar 17 2015 | FGEN | FIBROGEN INC | Controneo Pat | VP, Finance and CFO | Option Exercise | A | 29.66 | 64,136 | 1,902,274 | 64,136 | |
| Mar 17 2015 | FGEN | FIBROGEN INC | Controneo Pat | VP, Finance and CFO | Grant | A | 0.00 | 32,068 | 0 | 100,068 | 68 K to 100.1 K (+47.16 %) |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 334,074 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 150,177 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | C | 0.00 | 225,000 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Buy | C | 0.00 | 233,699 | 0 | 605,713 | 372 K to 605.7 K (+62.82 %) |
| Nov 21 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Buy | C | 0.00 | 110,000 | 0 | 530,200 | 420.2 K to 530.2 K (+26.18 %) |
| Nov 21 2014 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | C | 0.00 | 10,989 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | C | 0.00 | 76,923 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Buy | C | 0.00 | 35,164 | 0 | 143,068 | 107.9 K to 143.1 K (+32.59 %) |
| Nov 21 2014 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | C | 0.00 | 54,803 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | C | 0.00 | 95,639 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | C | 0.00 | 60,176 | 0 | 60,176 | 0 to 60.2 K |
| Nov 21 2014 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | C | 0.00 | 150,234 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | C | 0.00 | 15,839 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | C | 0.00 | 584,633 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | C | 0.00 | 85,967 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Buy | C | 0.00 | 334,666 | 0 | 468,631 | 134 K to 468.6 K (+249.82 %) |
| Nov 21 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | C | 0.00 | 131,870 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | C | 0.00 | 107,142 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | C | 0.00 | 42,236 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | C | 0.00 | 166,437 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | C | 0.00 | 1,160 | 0 | 0 | |
| Nov 21 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Buy | C | 0.00 | 179,536 | 0 | 185,536 | 6 K to 185.5 K (+2,992.27 %) |
| Nov 19 2014 | FGEN | FIBROGEN INC | Astellas Pharma Inc. | Option Exercise | C | 0.00 | 6,666,667 | 0 | 0 | ||
| Nov 19 2014 | FGEN | FIBROGEN INC | Astellas Pharma Inc. | Option Exercise | C | 0.00 | 1,208,800 | 0 | 0 | ||
| Nov 19 2014 | FGEN | FIBROGEN INC | Astellas Pharma Inc. | Option Exercise | C | 0.00 | 4,545,454 | 0 | 0 | ||
| Nov 19 2014 | FGEN | FIBROGEN INC | Astellas Pharma Inc. | Buy | C | 0.00 | 4,968,367 | 0 | 4,968,367 | 0 to 5 M | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | MADERO MIGUEL | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 18.00 | 6,000 | 108,000 | 6,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Option Exercise | A | 18.00 | 56,000 | 1,008,000 | 56,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Yu K Peony | VP, Clinical Develo ... | Grant | A | 0.00 | 28,000 | 0 | 171,000 | 143 K to 171 K (+19.58 %) |
| Nov 17 2014 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | A | 18.00 | 6,000 | 108,000 | 6,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | STERN JULIAN N | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Controneo Pat | VP, Finance and CFO | Option Exercise | A | 18.00 | 56,000 | 1,008,000 | 56,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Controneo Pat | VP, Finance and CFO | Grant | A | 0.00 | 28,000 | 0 | 68,000 | 40 K to 68 K (+70.00 %) |
| Nov 17 2014 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Option Exercise | A | 18.00 | 60,000 | 1,080,000 | 60,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | VALONE FRANK H MD | Chief Medical Offic ... | Grant | A | 0.00 | 30,000 | 0 | 54,000 | 24 K to 54 K (+125.00 %) |
| Nov 17 2014 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | A | 18.00 | 12,000 | 216,000 | 12,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | A | 18.00 | 140,000 | 2,520,000 | 140,000 | |
| Nov 17 2014 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Grant | A | 0.00 | 70,000 | 0 | 3,843,162 | 3.8 M to 3.8 M (+1.86 %) |